We have previously identified that blocking STAT3 signaling using STAT3β, a splice variant of STAT3 can enhance chemotherapy and chemoradiotherapy sensitivity in ESCC [45–47]. Here, STAT3 is linked to esophageal squamous cell carcinoma.